vbi-1501
Vaccineexperimental
Clinical trial activity
1 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2016 (NCT02826798)
Timeline
2010s
- Jan 1, 2016
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- CytomegalovirusImmunity, active
Cytomegalovirus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- vbi-1501
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02826798 | Phase 1 | Jun 1, 2016 | Clinical Trial Data Services, LLC, Dalhousie University, VBI Vaccines Inc., Virginia Commonwealth University |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Clinical Trial Data Services, LLC | For profit | 1 | 0 | 1 | 2016 |
| Dalhousie University | Academic/Hospital | 1 | 0 | 1 | 2016 |
| VBI Vaccines Inc. | For profit | 1 | 1 | 1 | 2016 |
| Virginia Commonwealth University | Academic/Hospital | 1 | 0 | 1 | 2016 |
4 organizations
Page 1 / 1